Sciences du Vivant

Targeting non-alcoholic fatty liver disease: Design, X-ray co-crystal structure and synthesis of ‘first-in-kind’ inhibitors of serine/threonine kinase25

Publié le 31 octobre 2022 - Bioorganic and Medicinal Chemistry Letters

Auteurs : Scarlett Kiyeleko, Sofiane Hocine, Giséle Mautino, Mélaine Kuenemann, Agata Nawrotek, Linda Miallau, Laurent-Michel Vuillard, Olivier Mirguet, Andras Kotschy, Stephen Hanessian